Transverse Medical raised $10M in Series B2 funding to expand operational infrastructure and grow its teams.

Apr 29, 2025•8 months ago

Amount Raised

$10 Million

Round Type

series b

DenverHealthcare

Investors

Series B1 InvestorsCompany’s Legacy Lead Investor

Description

Transverse Medical, a Denver-based medical device company, raised $10M in Series B2 funding. The funding will support the expansion of operational infrastructure and growth of engineering, regulatory, and operating teams. Backers included the Company’s Legacy Lead investor and Series B1 investors. Transverse focuses on cerebral embolic protection during TAVR procedures.

Company Information

Company

Transverse Medical

Location

Denver, Colorado, United States

About

Transverse Medical Inc. (TMI) is developing the POINT-GUARD™ Cerebral Embolic Protection (CEP) medical device to address the unmet need for Full Brain Protection and the clinical problem of periprocedural Stroke in Structural Heart Procedures, such as Transcatheter Aortic Valve Replacement (TAVR).

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends